Oncolytics Biotech Inc. (ONCY)
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Jared Kelly J.D., L.L.M.
|
CEO & Director | 582.15k | -- | 1986 |
|
Mr. Kirk J. Look C.A., CPA
|
Chief Financial Officer | 575.18k | -- | 1972 |
|
Dr. Thomas C. Heineman M.D., Ph.D.
|
Chief Medical Officer | 675.47k | -- | 1959 |
|
Mr. John McAdory
|
Chief Operating Officer | -- | -- | 1977 |
|
Ms. Allison Hagerman P.Eng., P.M.P.
|
Chief Technology Officer | 348.24k | -- | 1984 |
|
Jon Patton
|
Director of Investor Relations & Communication | -- | -- | -- |
|
Mr. Andrew P. Aromando
|
Chief Business Officer | -- | -- | 1969 |
|
Yujun Wu
|
VP & Head of Biostatistics | -- | -- | -- |
|
Mr. John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A.
|
Consultant | 18.5k | -- | -- |
Oncolytics Biotech Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 29
Description
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (GI) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Corporate Governance
Upcoming Events
November 16, 2026 at 9:00 PM UTC
Oncolytics Biotech Inc. Earnings Date
